NCT06316154

Brief Summary

The objective of the study is to determine the presence of germinal elements of echinococcosis in the liver parenchyma next to and in the thickness of the fibrous capsule of hydatid cysts.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Oct 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Oct 2023Dec 2026

Study Start

First participant enrolled

October 22, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 12, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 18, 2024

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 22, 2026

Expected
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2026

Last Updated

December 30, 2025

Status Verified

September 1, 2025

Enrollment Period

3.2 years

First QC Date

March 12, 2024

Last Update Submit

December 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of viable germinal elements of echinococcosis

    Identification of viable germinal elements of echinococcosis according to morphological analysis

    1 day

Secondary Outcomes (1)

  • Recurrence of liver echinococcosis

    1 year

Interventions

Echinococcectomy with subsequent pathomorphological analysis of liver parenchyma next to and in the thickness of the fibrous capsule

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with primary or recurrent liver echinococcosis

You may qualify if:

  • Presence of primary or recurrent liver echinococcosis disease requiring surgical treatment
  • Cyst diametr \>5 cm;
  • Performing one of the surgical treatment of liver echinococcosis with intraoperative sampling of part of the fibrous capsule with or without adjacent liver tissue for research;

You may not qualify if:

  • Liver echinococcosis with cysts less than 5 cm in diametr;
  • Presence of severe concomitant disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Republican specialized scientific and practical medical center of surgery named after academician V.Vakhidov

Tashkent, Uzbekistan, 100115, Uzbekistan

RECRUITING

MeSH Terms

Conditions

Echinococcosis, Hepatic

Condition Hierarchy (Ancestors)

EchinococcosisCestode InfectionsHelminthiasisParasitic DiseasesInfectionsLiver Diseases, ParasiticLiver DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 12, 2024

First Posted

March 18, 2024

Study Start

October 22, 2023

Primary Completion (Estimated)

December 22, 2026

Study Completion (Estimated)

December 25, 2026

Last Updated

December 30, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations